WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005065348) TRANSACTIVATION SYSTEM FOR MAMMALIAN CELLS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/065348    International Application No.:    PCT/US2004/043830
Publication Date: 21.07.2005 International Filing Date: 30.12.2004
Chapter 2 Demand Filed:    06.07.2005    
IPC:
C12N 15/63 (2006.01), C12N 15/85 (2006.01)
Applicants: KALOBIOS, INC. [US/US]; 3427 Hillview Avenue, Palo Alto, CA 94304 (US) (For All Designated States Except US).
BEBBINGTON, Christopher, Robert [GB/US]; (US) (For US Only).
YU, Bo [CN/US]; (US) (For US Only)
Inventors: BEBBINGTON, Christopher, Robert; (US).
YU, Bo; (US)
Agent: KUMAMOTO, Andrew, A.; McDermott, Will & Emery LLP, 18191 Von Karman Avenue, Suite 400, Irvine, CA 92612-7107 (US)
Priority Data:
60/533,917 31.12.2003 US
Title (EN) TRANSACTIVATION SYSTEM FOR MAMMALIAN CELLS
(FR) SYSTEME DE TRANSACTIVATION DE CELLULES MAMMALIENNES
Abstract: front page image
(EN)The present invention is directed generally to compositions and methods for expressing recombinant proteins in a mammalian host cell using a co-expressed transcriptional activator. In particular, the invention provides vectors, host cells, and methods of expressing at least one desired polypeptide by transfecting a mammalian host cell with cistrons encoding a transactivator, a desired polypeptide, and an apoptosis-protective protein.
(FR)La présente invention concerne d'une façon générale des compositions et des techniques permettant d'exprimer des protéines de recombinaison dans une cellule hôte mammalienne au moyen d'un activateur transcriptionnel co-exprimé. Cette invention concerne en particulier des vecteurs, des cellules hôtes et des techniques d'expression d'au moins un polypeptide recherché par la transfection d'une cellule hôte mammalienne avec des cistrons codant pour un transactivateur, un polypeptide recherché et une protéine de protection contre l'apoptose.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)